GB779109A - A therapeutic composition containing an n-benzhydryl-n-benzyl piperazine derivative - Google Patents

A therapeutic composition containing an n-benzhydryl-n-benzyl piperazine derivative

Info

Publication number
GB779109A
GB779109A GB32171/55A GB3217155A GB779109A GB 779109 A GB779109 A GB 779109A GB 32171/55 A GB32171/55 A GB 32171/55A GB 3217155 A GB3217155 A GB 3217155A GB 779109 A GB779109 A GB 779109A
Authority
GB
United Kingdom
Prior art keywords
piperazine
hydrogen
derivative
piperazine derivative
pyridoxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32171/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB779109A publication Critical patent/GB779109A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Piperazine derivatives of the formula <FORM:0779109/IV(b)/1> where X is hydrogen or halogen, e.g. chlorine, and Y is hydrogen or lower alkyl (C1 to C6) group e.g. meta-methyl, are prepared by alkylation of piperazine under reductive conditions with a benzophenone derivative and a benzyl halide in either order, and admixed with pyridoxin in therapeutic compositions.ALSO:A therapeutic composition comprises pyridoxine with a piperazine derivative of formula: <FORM:0779109/VI/1> where X is hydrogen or halide, and Y is hydrogen or a lower alkyl (C1 to C6) group. The piperazine derivative may be used in the form of a water soluble salt e.g. dihydrochloride or dihydrobromide; or a salt of a non-toxic organic acid, e.g. citric, tartaric, acetic, succinic, maleic, glycolic, gluconic, glutaric or saccharic acid. The pyridoxin may be used as the hydrochloride or as a water soluble salt e.g. citrate, tartrate or acetate. The composition contains from one quarter to two parts by weight of the piperazine derivative, to one part by weight of pyridoxine. The example refers to tablets containing N - (p - chlorobenzhydryl) - N1 - (meta methyl benzyl) piperazine with pyridoxine hydrochloride.
GB32171/55A 1954-12-28 1955-11-10 A therapeutic composition containing an n-benzhydryl-n-benzyl piperazine derivative Expired GB779109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US779109XA 1954-12-28 1954-12-28

Publications (1)

Publication Number Publication Date
GB779109A true GB779109A (en) 1957-07-17

Family

ID=22140741

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32171/55A Expired GB779109A (en) 1954-12-28 1955-11-10 A therapeutic composition containing an n-benzhydryl-n-benzyl piperazine derivative

Country Status (1)

Country Link
GB (1) GB779109A (en)

Similar Documents

Publication Publication Date Title
ES449740A1 (en) 1-(benzazolylalkyl)piperidine derivatives
GB779109A (en) A therapeutic composition containing an n-benzhydryl-n-benzyl piperazine derivative
ES465537A1 (en) Novel benzylalcohol derivatives and processes for preparing the same
GB939901A (en) Improvements in or relating to amino pyrazoles
GB904956A (en) Anthelmintic compositions containing nitrophenol derivatives
DE3380876D1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US2652417A (en) 1, 2, 3, 10b-tetrahydrofluoranthene-10b-carboxylic acid
GB808049A (en) Phenothiazine derivatives
GB970597A (en) Therapeutic compositions containing n-substituted 4-aralkyl-piperidines
GB810304A (en) Improvements in or relating to amines
GB914524A (en) Thiazole carboxylic acid-(5-nitrofuryl-2-methylidene)-hydrazides and process for their manufacture
ES397787A1 (en) Indole derivatives nad compositions containing the same
GB743495A (en) Therapeutically active benzhydryl derivatives and processes of manufacturing the same
ES245955A1 (en) Novel tertiary amines and processes for their production
GB846560A (en) Improvements in indole derivatives
GB945095A (en) Preparation for the treatment of vascular headache
GB882357A (en) Arylene-imidazolium compounds and disinfectant compositions containing them
GB942876A (en) Improvements in or relating to piperidylidene-thiaxanthene
GB843908A (en) Novel morphinan derivatives and the manufacture thereof
GB840239A (en) New anthelmintic compositions
GB1172788A (en) N-(Azabicycloalkylisopropyl)-Aminopyridine Derivatives
GB803750A (en) Aqueous solutions of salts of di-(4-amidinophenyl)-triazene-(n-1:3) and process for preparing them
JPS51125281A (en) A process for preparing indazole derivatives
GB882894A (en) Phenothiazine-derivatives
GB762720A (en) Novel morpholinomethyl-phenyl derivatives and the manufacture thereof